Standard
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. / Bohr, Adam; Nascimento, Thais Leite; Harmankaya, Necati; Weisser, Johan Juhl; Wang, Yingya; Grohganz, Holger; Rades, Thomas; Löbmann, Korbinian.
In:
Molecules, Vol. 24, No. 2, 266, 2019.
Research output: Contribution to journal › Journal article › peer-review
Harvard
Bohr, A, Nascimento, TL, Harmankaya, N, Weisser, JJ, Wang, Y
, Grohganz, H, Rades, T & Löbmann, K 2019, '
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy',
Molecules, vol. 24, no. 2, 266.
https://doi.org/10.3390/molecules24020266
APA
Bohr, A., Nascimento, T. L., Harmankaya, N., Weisser, J. J., Wang, Y.
, Grohganz, H., Rades, T., & Löbmann, K. (2019).
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.
Molecules,
24(2), [266].
https://doi.org/10.3390/molecules24020266
Vancouver
Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y
, Grohganz H et al.
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.
Molecules. 2019;24(2). 266.
https://doi.org/10.3390/molecules24020266
Author
Bohr, Adam ; Nascimento, Thais Leite ; Harmankaya, Necati ; Weisser, Johan Juhl ; Wang, Yingya ; Grohganz, Holger ; Rades, Thomas ; Löbmann, Korbinian. / Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. In: Molecules. 2019 ; Vol. 24, No. 2.
Bibtex
@article{5533bc5fd9294ce296daf23adc46cbec,
title = "Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy",
author = "Adam Bohr and Nascimento, {Thais Leite} and Necati Harmankaya and Weisser, {Johan Juhl} and Yingya Wang and Holger Grohganz and Thomas Rades and Korbinian L{\"o}bmann",
year = "2019",
doi = "10.3390/molecules24020266",
language = "English",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "M D P I AG",
number = "2",
}
RIS
TY - JOUR
T1 - Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy
AU - Bohr, Adam
AU - Nascimento, Thais Leite
AU - Harmankaya, Necati
AU - Weisser, Johan Juhl
AU - Wang, Yingya
AU - Grohganz, Holger
AU - Rades, Thomas
AU - Löbmann, Korbinian
PY - 2019
Y1 - 2019
U2 - 10.3390/molecules24020266
DO - 10.3390/molecules24020266
M3 - Journal article
C2 - 30642009
VL - 24
JO - Molecules
JF - Molecules
SN - 1420-3049
IS - 2
M1 - 266
ER -